Detalhe da pesquisa
1.
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
Hepatology
; 61(4): 1145-53, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25431357
2.
OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.
Liver Int
; 35(1): 120-9, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041136
3.
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.
Gut
; 62(2): 290-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22859496
4.
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a.
J Hepatol
; 56(5): 1006-1011, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22245886
5.
Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.
J Womens Health (Larchmt)
; 24(2): 159-64, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25682817
6.
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study.
Antivir Ther
; 20(1): 39-48, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24831457
7.
Real-world outcomes in patients with chronic hepatitis C: primary results of the PROBE study.
Eur J Gastroenterol Hepatol
; 26(4): 388-95, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24569819
8.
OPERA: use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients.
Antivir Ther
; 19(8): 735-45, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24583976